Theriva Biologics says Nature Medicine publishes VIRAGE Phase 2b results
Peer-reviewed publication covers VCN-01 in metastatic pancreatic cancer and reports improved survival-related outcomes versus chemotherapy alone.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Theriva Biologics publishes VIRAGE phase 2b results
Theriva Biologics said results from the VIRAGE phase 2b clinical trial of VCN-01 in metastatic pancreatic cancer were published in Nature Medicine.